JPMORGAN CHASE & CO
Position in PACB — Pacific Biosciences Of California, Inc.
CIK 19617
NEW YORK, NY
Position in PACB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$245,191
+$62,368 QoQ
Shares Held
145,948
+5.4% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 222 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in PACB Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $14,252,029,704 across 101 Medical Devices names. PACB ranks #63 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
17,260,943 | $5,434,435,284 | |
| 2 | MDT |
Medtronic plc
|
27,784,471 | $2,173,579,157 | |
| 3 | EW |
Edwards Lifesciences Corp
|
22,783,175 | $2,060,966,003 | |
| 4 | ABT |
Abbott Laboratories
|
15,095,898 | $1,369,801,775 | |
| 5 | BSX |
Boston Scientific Corp
|
23,907,838 | $1,020,386,517 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
10,329,164 | $661,169,779 | |
| 7 | PEN |
Penumbra Inc
|
1,071,454 | $338,311,597 | |
| 8 | DXCM |
Dexcom Inc
|
3,325,095 | $223,945,140 |
All Filings in PACB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $245,191 | 145,948 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $182,823 | 138,504 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $854,416 | 456,908 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $600,165 | 468,880 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $595,821 | 480,502 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $615,172 | 521,334 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $941,543 | 514,505 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $959,661 | 564,507 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $710,413 | 518,550 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $3,230,223 | 861,393 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $12,588,895 | 1,283,272 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $12,545,330 | 1,502,435 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $17,674,008 | 1,328,873 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $13,998,782 | 1,208,876 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $6,678,323 | 816,421 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,171,137 | 717,924 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,440,631 | 778,424 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $9,243,950 | 1,015,819 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $5,466,684 | 267,189 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $6,339,897 | 248,137 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $10,456,517 | 299,014 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $19,602,632 | 588,491 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $5,806,694 | 223,851 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $613,904 | 62,199 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $168,843 | 48,940 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $3,329,726 | 1,088,146 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||